Valuation: Check-Cap

Market Cap 88.92L 77.78L 71.74L 66.26L 1.26Cr 85Cr 1.28Cr 8.57Cr 3.37Cr 42Cr 3.34Cr 3.27Cr 143.62Cr P/E 2024
-0.23x
P/E 2025 2.44x
Enterprise Value 86.89L 76L 70.1L 64.75L 1.23Cr 83Cr 1.25Cr 8.38Cr 3.29Cr 41Cr 3.26Cr 3.19Cr 140.34Cr EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-0.81%
1 week+7.02%
Current month-2.40%
1 month-8.27%
3 months-27.38%
6 months-30.68%
Current year-24.69%
1 week 1.09
Extreme 1.0901
1.23
1 month 1.06
Extreme 1.0566
1.47
Current year 1.06
Extreme 1.0566
3.92
1 year 0.59
Extreme 0.593
3.92
3 years 0.56
Extreme 0.56
4.62
5 years 0.56
Extreme 0.56
26.2
10 years 0.56
Extreme 0.56
820.8
Manager TitleAgeSince
Chief Executive Officer 45 17/07/2024
Director of Finance/CFO 51 06/04/2025
Human Resources Officer - 01/01/2009
Director TitleAgeSince
Director/Board Member 53 25/01/2024
Chairman 45 25/01/2024
Director/Board Member 54 25/01/2024

Financials

2024 2025
Net sales - -
Net income -2.51Cr -2.2Cr -2.03Cr -1.87Cr -3.56Cr -239.86Cr -3.62Cr -24Cr -9.52Cr -118.16Cr -9.44Cr -9.24Cr -406.21Cr 41.4L 36.21L 33.4L 30.85L 58.54L 39Cr 59.52L 3.99Cr 1.57Cr 19Cr 1.55Cr 1.52Cr 67Cr
Net Debt -1L -1L -1L -96.13T -2L -1.23Cr -2L -12.44L -5L -60.61L -5L -5L -2.08Cr -2L -2L -2L -2L -3L -1.94Cr -3L -19.57L -8L -95.38L -8L -7L -3.28Cr
Logo Check-Cap
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Employees
85
Sector
-
Date Price Change Volume
10/26/10 $1.220 -0.81% 21,575
09/26/09 $1.230 +8.85% 34,797
08/26/08 $1.130 -0.88% 13,635
07/26/07 $1.140 -1.72% 31,772
06/26/06 $1.160 +1.75% 18,764
  1. Stock Market
  2. Stocks
  3. MBAI Stock